Solitary Plasmacytoma of Bone of the Spine: Results From Surveillance, Epidemiology, and End Results (SEER) Registry. 2019

Yufu Wang, and Hui Li, and Chao Liu, and Chao Chen, and Jinglong Yan
Department of Orthopedic Surgery, Second Affiliated Hospital, Harbin Medical University, Harbin, China.

METHODS Retrospective analysis. OBJECTIVE To determine the prognostic indicators in patients with solitary plasmacytoma of bone (SPB) of the spine. BACKGROUND Population-level estimates for prognosis among patients with SPB of the spine are still lacking. Sociodemographic and clinical predictors of outcome have not been well characterized. METHODS The Surveillance, Epidemiology, and End Results Registry was used to identify all patients with SPB of the spine from 1995 through 2014. Associated population data were used to determine annual incidence and limited-duration prevalence. Overall survival (OS) estimates were obtained using the Kaplan-Meier method and compared across groups using log-rank test. A Cox regression model was used for multivariate analysis of survival. Logistic regression was performed to identify predictors of the progression to multiple myeloma (MM). RESULTS The incidence and prevalence of the disease increased during the study period. Spinal SPB most commonly affected older people (>50) with a male preponderance. The median OS were 74.0 months. The 5 and 10-year survival rates for these patients were 56.1% and 36.7%, respectively. On multivariable analyses, older age, and surgery without radiotherapy were correlated with poor survival of patients with spinal SPB. The 3-year probability of progression to MM was 10.1%. Patients aged >70 years were associated with progression to MM. There was no significant association between the methods of surgical resection (radical or local/partial) and OS or progression to MM. CONCLUSIONS The findings of this study provide population-based estimates of the incidence, prevalence and prognosis for patients with SPB of the spine. This analysis indicated that the only identifiable prognostic indicators were older age and surgery without radiotherapy. Moreover, the methods of surgical resection did not influence the OS or progression to MM. METHODS 4.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009101 Multiple Myeloma A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY. Myeloma, Plasma-Cell,Kahler Disease,Myeloma, Multiple,Myeloma-Multiple,Myelomatosis,Plasma Cell Myeloma,Cell Myeloma, Plasma,Cell Myelomas, Plasma,Disease, Kahler,Multiple Myelomas,Myeloma Multiple,Myeloma, Plasma Cell,Myeloma-Multiples,Myelomas, Multiple,Myelomas, Plasma Cell,Myelomas, Plasma-Cell,Myelomatoses,Plasma Cell Myelomas,Plasma-Cell Myeloma,Plasma-Cell Myelomas
D010954 Plasmacytoma Any discrete, presumably solitary, mass of neoplastic PLASMA CELLS either in BONE MARROW or various extramedullary sites. Plasma Cell Tumor,Plasmocytoma,Plasma Cell Tumors,Plasmacytomas,Plasmocytomas,Tumor, Plasma Cell,Tumors, Plasma Cell
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000367 Age Factors Age as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or the effect of a circumstance. It is used with human or animal concepts but should be differentiated from AGING, a physiological process, and TIME FACTORS which refers only to the passage of time. Age Reporting,Age Factor,Factor, Age,Factors, Age
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

Yufu Wang, and Hui Li, and Chao Liu, and Chao Chen, and Jinglong Yan
January 2012, Current problems in cancer,
Yufu Wang, and Hui Li, and Chao Liu, and Chao Chen, and Jinglong Yan
December 2017, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie,
Yufu Wang, and Hui Li, and Chao Liu, and Chao Chen, and Jinglong Yan
October 1992, Revista clinica espanola,
Yufu Wang, and Hui Li, and Chao Liu, and Chao Chen, and Jinglong Yan
January 2003, The oncologist,
Yufu Wang, and Hui Li, and Chao Liu, and Chao Chen, and Jinglong Yan
January 2014, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus,
Yufu Wang, and Hui Li, and Chao Liu, and Chao Chen, and Jinglong Yan
March 2020, Clinical lung cancer,
Yufu Wang, and Hui Li, and Chao Liu, and Chao Chen, and Jinglong Yan
April 2018, Journal of neurosurgery,
Yufu Wang, and Hui Li, and Chao Liu, and Chao Chen, and Jinglong Yan
April 2000, International journal of epidemiology,
Yufu Wang, and Hui Li, and Chao Liu, and Chao Chen, and Jinglong Yan
August 2019, Journal of neuro-oncology,
Copied contents to your clipboard!